Germany Hepatitis C Testing Market to 6.1% CAGR till 2027; Investments by Government to Prevent New Cases of HCV will Ai

Коментари · 646 Виждания

Germany Hepatitis C Testing Market: CDC Recommends Taking Antibodies Test 4 to 6 Months Following Exposure to HCV

The “Germany hepatitis C testing market“ size is projected to reach USD 121.4 million in 2027. Fortune Business Insights™ presented this information in a new report, titled, “Germany Hepatitis C Testing Market, 2020-2027.” The report further states that the market stood at USD 106.8 million in 2019. It is set to exhibit a CAGR of 6.1% during the forecast period between 2020-2027. The Government of Germany has implemented a strategic plan to eliminate hepatitis C in the country. As per a study published by BMC Infectious Diseases, for instance, the total number of patients suffering from HCV is estimated to reduce to 125,000 (no screening) and 14,000 (total screening) from 275,000 in 2015.

Request a Sample Copy of the Research Report: 

https://www.fortunebusinessinsights.com/enquiry/sample/germany-hepatitis-c-testing-market-104866

COVID-19 Pandemic: Postponement of Non-critical Tests to Impact Growth Negatively

In December 2020, the Journal of Primary Care and Community Health mentioned that the COVID-19 pandemic has resulted in a 50% decline in the hepatitis C testing. It proves that the pandemic has affected the market for Germany hepatitis C testing negatively as the testing of non-critical patients was considered unessential. The priority was mainly given to coronavirus positive patients. Our in-depth research reports will help you overcome the current situation by adopting novel strategies.

An Overview of the Impact of COVID-19 on this Market :

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/germany-hepatitis-c-testing-market-104866

Segmentation-

Hospitals Segment to Generate the Largest Share in the Upcoming Years

Our team of highly skilled analysts has segregated the industry on the basis of test type, technology type, and end-users. By end-users, the market is fragmented into diagnostics labs, hospitals, and others. Amongst them, the hospitals segment is expected to earn the largest Germany hepatitis C testing market share in the forthcoming years. This growth is attributable to the presence of a large number of hospitals and clinics in Germany that provide hepatitis C testing services. On the basis of technology type, it is bifurcated into PCR and ELISA.

By test types, it is segmented into HCV genotype tests, HCV RNA tests, and HCV serologic tests (HCV Ab). Out of these, the HCV RNA tests segment held a share of 6.1% in 2019. It is set to remain in the second position stoked by the increasing need to detect viral load during monitoring tests.

Quick Buy - Germany Hepatitis C Testing Market Research Report: 

https://www.fortunebusinessinsights.com/checkout-page/104866

Report Coverage-

The Germany hepatitis C testing research report aims to analyze the market by considering contributions, prospects, and growth trends. It presents detailed profiles of every key player operating in the market to analyze their core competencies in each segment. Apart from that, it ensures to help our clients better understand the competitive developments, such as mergers acquisitions, new product launches, joint ventures, and collaborations. 

Drivers Restraints-

Fortune Business Insights™ Says Rising Awareness Programs about Timely Diagnosis to Boost Growth

Awareness programs regarding the benefits of timely diagnostics of HCV infection are increasing rapidly in Germany. Majority of the population affected by this disease often develop the chronic form of it very quickly. It further leads to the occurrences of serious ailments, such as liver failure and liver cancer. At the same time, the government is investing huge sums to take initiatives for preventing more cases of HCV by developing unique hepatitis C testing services in this country. However, the lack of HCV testing facilities in the country may obstruct the Germany hepatitis C testing market growth in the near future.

Коментари